VEA
COGT icon

Virtus ETF Advisers’s Cogent Biosciences COGT Stock Holding History

Virtus ETF Advisers’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$446K Buy
+11,524
New +$403K 0.17% 156
2025
Q1 		– Sell
-8,524
Closed -$66.5K – 507
2024
Q4 		$66.5K Sell
8,524
-1,742
-17% -$17.4K 0.03% 408
2024
Q3 		$111K Buy
10,266
+185
+2% +$1.8K 0.05% 361
2024
Q2 		$85K Sell
10,081
-7,386
-42% -$56K 0.04% 382
2024
Q1 		$117K Sell
17,467
-1,199
-6% -$7.41K 0.06% 348
2023
Q4 		$110K Buy
18,666
+10,966
+142% +$84K 0.07% 330
2023
Q3 		$75.1K Sell
7,700
-762
-9% -$9.04K 0.05% 373
2023
Q2 		$100K Buy
8,462
+95
+1% +$1.09K 0.06% 380
2023
Q1 		$90.3K Sell
8,367
-3,209
-28% -$41K 0.05% 364
2022
Q4 		$134K Buy
+11,576
New +$143K 0.07% 383
2022
Q2 		– Sell
-19,452
Closed -$146K – 448
2022
Q1 		$146K Sell
19,452
-1,158
-6% -$8.06K 0.07% 228
2021
Q4 		$177K Sell
20,610
-2,725
-12% -$23.7K 0.07% 256
2021
Q3 		$196K Sell
23,335
-1,219
-5% -$9.34K 0.09% 274
2021
Q2 		$199K Sell
24,554
-3,547
-13% -$30K 0.08% 351
2021
Q1 		$247K Buy
+28,101
New +$271K 0.1% 292

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Virtus ETF Advisers's COGT Position: Q2 2026 in Review

Virtus ETF Advisers opened a new position in Cogent Biosciences (COGT) in Q2 2026: 11,524 shares worth $446K. The stake represents 0.17% of the portfolio and ranks #156 among its holdings. This is a return to the name: Virtus ETF Advisers previously reported a position in COGT as recently as Q4 2024.

Virtus ETF Advisers first reported a position in COGT in Q1 2021 and has held it in 15 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Virtus ETF Advisers held 11,524 shares of Cogent Biosciences worth $446K as of Q2 2026.
  • Cogent Biosciences was a new Virtus ETF Advisers position in Q2 2026.
  • Cogent Biosciences made up 0.17% of Virtus ETF Advisers's portfolio in Q2 2026, its #156 holding.
  • Virtus ETF Advisers first reported a position in Cogent Biosciences in Q1 2021 and has held it in 15 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.